Vetter, which happens to be a global CDMO, has gone on to receive permanent Manufacturer Authorization as far as its clinical development site in Rankweil, Austria, is concerned. Functional for almost a couple of years, the responsible national regulatory authority, which in this case is the Austrian Agency for Health and Food Safety- AGES has […]

The post Permanent Manufacturer Authorization For Vetter, Rankweil first appeared on World Pharma Today.